Search Results 501-510 of 18228 for Immunode

1. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer - Mayo Clinic

   Diagnosis of immunodeficiency or receiving systemic steroid therapy or any ... Known history of human immunodeficiency virus (HIV) (HIV 1/2 antibodies).

2. Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation - Mayo Clinic

   Medical history of human immunodeficiency virus or syphilis infection. 13. Known active hepatitis B or hepatitis C infection at the time of screening. 14. A ...

3. A Study of R-ICE and Lenalidomide for Treating Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Immunocompromised patients and patients known to be human immunodeficiency virus (HIV) positive and currently receiving antiretroviral therapy. Patients ...

4. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   Known active hepatitis B or C, or human immunodeficiency virus (HIV) infection; Subjects who, in the opinion of the Investigator, are unable or unlikely to ...

5. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

   Known human immunodeficiency virus or hepatitis C infection only if the patient is taking medications that are excluded per protocol, active hepatitis B, or ...

6. MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer - Mayo Clinic

   HIV-positive test result, or history of other immunodeficiency. History of organ transplantation. History of chronic hepatitis B or C. Other concurrent ...

7. Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Systemic Sclerosis - Mayo Clinic

   Positive test for human immunodeficiency virus, hepatitis C antibody, hepatitis B surface antigen, or evidence of active or chronic tuberculosis at Screening.

8. A Study Of Tolododekin Alfa (ANK-101) In Combination With An Anti-PD-1/PD-L1 Antibody In Participants With Advanced Non-Small Cell Lung Cancer - Mayo Clinic

   Human immunodeficiency virus (HIV)-infected participants must be on anti-retroviral therapy (ART) and have well-controlled HIV infection/disease. Resolution ...

9. Anaplastic large cell lymphoma - Symptoms and causes - Mayo Clinic

   Infection with human immunodeficiency virus (HIV). People with HIV have weakened immune systems. That increases the risk of ALK-negative ALCL. Ongoing ...

10. Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    History of active primary immunodeficiency; Known history of previous tuberculosis; Active infection including hepatitis B, hepatitis C or human ...